secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001493152-24-017488
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01, 3.03, 5.03, 5.08, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals granted Nasdaq bid-price extension to Oct 24 and conditional equity compliance
--------------------------------------------------------------------------------

- Received 180-day extension until Oct 24, 2024 to meet $1.00 minimum bid price requirement.
- Nasdaq conditionally approved $2.5M stockholders' equity compliance based on April 25 8-K; must re-demonstrate in next periodic report.
- Filed Certificate of Correction for Series C Preferred stock to fix cross-references, effective April 29, 2024.
- 2024 Annual Meeting set for June 17, 2024; stockholder proposals due May 13, 2024.
- Shareholders authorized reverse stock split (1:2 to 1:50) at March 25 special meeting, may be used to regain bid price compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224017488/0001493152-24-017488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224017488/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer